{"id":"NCT01243424","sponsor":"Boehringer Ingelheim","briefTitle":"CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes","officialTitle":"A Multicentre, International, Randomised, Parallel Group, Double Blind Study to Evaluate Cardiovascular Safety of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-11-11","primaryCompletion":"2018-08-21","completion":"2018-08-21","firstPosted":"2010-11-18","resultsPosted":"2020-01-07","lastUpdate":"2020-01-07"},"enrollment":6103,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"linagliptin","otherNames":[]},{"type":"DRUG","name":"glimepiride","otherNames":[]},{"type":"DRUG","name":"linagliptin placebo","otherNames":[]},{"type":"DRUG","name":"glimepiride placebo","otherNames":[]}],"arms":[{"label":"linagliptin","type":"EXPERIMENTAL"},{"label":"glimepiride 1-4 mg QD","type":"ACTIVE_COMPARATOR"}],"summary":"The aim of the study is to investigate the longterm impact on cardiovascular morbidity and mortality, relevant efficacy parameters (e.g., glycaemic parameters) and safety (e.g., weight and hypoglycaemia) of treatment with linagliptin in patients with type 2 diabetes at elevated cardiovascular risk receiving usual care, and compare outcome against glimepiride.","primaryOutcome":{"measure":"The First 3-point Major Adverse Cardiovascular Events (3P-MACE)","timeFrame":"From randomization until individual day of trial completion, up to 432 weeks","effectByArm":[{"arm":"Linagliptin","deltaMin":20.7,"sd":null},{"arm":"Glimepiride","deltaMin":21.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"0.3813"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":613,"countries":["United States","Argentina","Australia","Belgium","Brazil","Bulgaria","Canada","Chile","Colombia","Czechia","Finland","France","Georgia","Germany","Greece","Hong Kong","Hungary","India","Ireland","Israel","Italy","Japan","Malaysia","Mexico","Netherlands","New Zealand","Norway","Peru","Philippines","Portugal","Romania","Russia","Serbia","Slovakia","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","Tunisia","Ukraine","United Kingdom"]},"refs":{"pmids":["38170502","37449424","36700391","36116359","34895804","33559704","31536101","30811335","30736150","29334906","25780262"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1403,"n":3023},"commonTop":["Hypoglycaemia","Nasopharyngitis","Hyperglycaemia","Hypertension","Back pain"]}}